Diabetes Core Update – April 2024

Apr 2, 2024

Exploring latest diabetes research: FDA approved therapies for fatty liver, outcomes of bariatric surgery vs. medical management in Type 2 diabetes, improved glycemic results with technology use in youth with Type 1 diabetes, cardiovascular and kidney risks in Type 2 diabetes, and significance of coronary artery calcium in prediabetes.

Ask episode

Chapters

Transcript

Episode notes

Introduction

00:00 • 2min

Exploring the Significance of FDA Approved Drug for Fatty Liver in Diabetic Patients

02:22 • 3min

Exploring a Phase Three Trial on Stiado-Hepatitis with Surrogate Endpoints

05:21 • 3min

Exploring the Mechanism and Benefits of Res Metarone for Liver Health and Lipid Profile

08:16 • 3min

Advancements in Drug Trial for Fatty Liver Disease

11:12 • 8min

Comparing Bariatric Surgery and Medical Management in Type 2 Diabetes

18:55 • 15min

Exploring the Impact of Diabetes Technology on Glycemic Outcomes in Youth with Type 1 Diabetes

33:29 • 3min

Cardiovascular and Kidney Risks in Type 2 Diabetes: Addressing Adiposity

36:55 • 17min

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 25 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

Welcome to diabetes core update where every month we go over the most important articles to come out in the field of diabetes. Articles that are important for practicing clinicians to understand to stay up with the rapid changes in the field.

This issue will review:

1. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

2. Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes

3. Improved Glycemic Outcomes With Diabetes Technology Use Independent of Socioeconomic Status in Youth With Type 1 Diabetes

4. Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity

5. Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Hosts:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health